Autres langues Edwards Lifesciences Corporation

Actions

EW

US28176E1082

Equipement et technologie médicale avancés

Marché Fermé - NYSE 22:00:03 17/09/2026			Varia. 5j.	Varia. 1 janv.
88,25 ^USD	-1,15 %		+1,71 %	+3,52 %

16/09	Transcript : Edwards Lifesciences Corporation Presents at Deutsche Bank 2026 Healthcare Summit, Sep-16-2026 10:00 AM
11/09	Edwards Lifesciences réaffirme ses prévisions pour 2026 après la décision de Medicare sur le TAVR	MT

Autres langues

11/09	Edwards Lifesciences Reaffirms 2026 Guidance Following Medicare TAVR Decision
10/09	Edwards Lifesciences Comments on TAVR National Coverage Decision
02/09	Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit
27/08	Edwards Lifesciences Insider Sold Shares Worth $2,894,440, According to a Recent SEC Filing
25/08	Do I Really Need To File? HSR Avoidance And The Edwards/Genesis Settlement (Podcast)
17/08	Becton Dickinson Names Gary Sorsher as Chief Quality Officer
05/08	FTC Reaches $12 Million Settlement Over Alleged HSR Act Violations
05/08	Edwards Lifesciences : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
04/08	Tranche Update on Edwards Lifesciences Corporation (NYSE:EW)'s Equity Buyback Plan announced on July 28, 2022.
29/07	Edwards Lifesciences Insider Sold Shares Worth $818,958, According to a Recent SEC Filing
24/07	Edwards Lifesciences Seen Building on Catalyst Pipeline, RBC Says
24/07	Unternehmenskalender vom 27. bis 31. Juli 2026
24/07	Substance Over Form: The FTC’s $12 Million HSR Evasion Penalty And What It Signals For Dealmakers
24/07	FTC Secures $12 Million In Penalties For Alleged HSR Violation
23/07	Edwards Lifesciences beats quarterly estimates on strong demand for heart devices
23/07	Stocks to Watch : Intel, Deckers, Edwards Lifesciences, Genmab
23/07	Edwards Lifesciences Q2 Adjusted Earnings, Revenue Rise; Q3 Guidance Set
23/07	(EW) Edwards Lifesciences Corporation Expects Q3 Revenue Range $1.63B - $1.71B
23/07	(EW) Edwards Lifesciences Corporation Expects Q3 Adjusted EPS Range $0.71 - $0.77
23/07	Earnings Flash (EW) Edwards Lifesciences Corporation Reports Q2 Revenue $1.74B, vs. FactSet Est of $1.70B
23/07	Earnings Flash (EW) Edwards Lifesciences Corporation Reports Q2 Revenue $1.74B, vs. FactSet Est of $1.70B
23/07	Earnings Flash (EW) Edwards Lifesciences Corporation Posts Q2 Adjusted EPS $0.78 per Share, vs. FactSet Est of $0.74
23/07	Edwards Lifesciences Reports Second Quarter Results
23/07	Edwards Lifesciences Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
23/07	Edwards Lifesciences Corporation Increases Earnings Guidance for the Full Year 2026